DK0659406T3 - Lægemiddelformulering med reguleret afgivelse - Google Patents

Lægemiddelformulering med reguleret afgivelse

Info

Publication number
DK0659406T3
DK0659406T3 DK94120709T DK94120709T DK0659406T3 DK 0659406 T3 DK0659406 T3 DK 0659406T3 DK 94120709 T DK94120709 T DK 94120709T DK 94120709 T DK94120709 T DK 94120709T DK 0659406 T3 DK0659406 T3 DK 0659406T3
Authority
DK
Denmark
Prior art keywords
inner layer
drug formulation
drug
water
biocompatible material
Prior art date
Application number
DK94120709T
Other languages
English (en)
Inventor
Keiji Fujioka
Kenji Hirasawa
Akihiro Sano
Yosuke Urabe
Takeshi Hirasawa
Masako Kajihara
Shuichi Sugawara
Original Assignee
Dow Corning Asia Ltd
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Asia Ltd, Sumitomo Pharma filed Critical Dow Corning Asia Ltd
Application granted granted Critical
Publication of DK0659406T3 publication Critical patent/DK0659406T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
DK94120709T 1993-12-27 1994-12-27 Lægemiddelformulering med reguleret afgivelse DK0659406T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33146793A JP3720386B2 (ja) 1993-12-27 1993-12-27 薬物放出制御製剤

Publications (1)

Publication Number Publication Date
DK0659406T3 true DK0659406T3 (da) 2000-07-03

Family

ID=18243976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94120709T DK0659406T3 (da) 1993-12-27 1994-12-27 Lægemiddelformulering med reguleret afgivelse

Country Status (15)

Country Link
US (1) US5851547A (da)
EP (1) EP0659406B1 (da)
JP (1) JP3720386B2 (da)
KR (1) KR100349960B1 (da)
CN (1) CN1107497C (da)
AT (1) ATE190836T1 (da)
AU (1) AU686713B2 (da)
CA (1) CA2139058C (da)
DE (1) DE69423582T2 (da)
DK (1) DK0659406T3 (da)
ES (1) ES2146633T3 (da)
GR (1) GR3033248T3 (da)
NZ (1) NZ277548A (da)
PT (1) PT659406E (da)
WO (1) WO1995017881A1 (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056734A (en) * 1997-02-07 2000-05-02 Sarcos Lc Method for automatic dosing of drugs
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
CA2291659A1 (fr) 1997-06-04 1998-12-10 Debio Recherche Pharmaceutique S.A. Implants pour la liberation controlee de principes pharmaceutiquement actifs et procede pour leur fabrication
TW586944B (en) 1998-05-29 2004-05-11 Sumitomo Pharma Controlled release agent having a multi-layer structure
US20020087184A1 (en) * 1998-06-18 2002-07-04 Eder Joseph C. Water-soluble coating for bioactive devices
MXPA01002609A (es) * 1998-09-10 2002-04-08 Sumitomo Pharma Preparacion de farmaco de liberacion sostenida a largo plazo.
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
AU3957400A (en) 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
BR0014141A (pt) * 1999-08-25 2002-07-16 Univ Georgetown Sistema de aplicação para terapia que compreende bulbos ocos, preferivelmente metálicos, e a sua utilização
TW524696B (en) 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
JP2002003406A (ja) * 2000-06-21 2002-01-09 Sankyo Co Ltd 脳血管攣縮予防製剤
ATE355813T1 (de) * 2000-07-14 2007-03-15 Novo Nordisk As Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
WO2003000156A1 (en) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
CN1638747A (zh) * 2002-01-24 2005-07-13 斯玛特药物系统公司 持续释放药物组合物
JP4026745B2 (ja) * 2002-03-26 2007-12-26 財団法人大阪産業振興機構 医療用システムおよびその製造方法
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
CA2487577C (en) 2002-05-31 2014-11-18 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of buprenorphine
SI1610791T1 (sl) 2003-03-31 2011-05-31 Titan Pharmaceuticals Inc Implantibilna polimerna naprava za zadržano sproščanje dopaminskega agonista
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
MXPA05012768A (es) * 2003-05-30 2006-02-22 Titan Pharmaceuticals Inc Dispositivo polimerico implantable para liberacion prolongada de nalmefeno.
WO2005000278A1 (en) * 2003-06-26 2005-01-06 Mediolanum Pharmaceuticals Ltd. Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof
PT1781264E (pt) 2004-08-04 2013-10-16 Evonik Corp Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
WO2007070494A2 (en) 2005-12-12 2007-06-21 Women & Infants Hospital Of Rhode Island Heterocycles and derivatives thereof and methods of manufacture and therapeutic use
WO2008060360A2 (en) * 2006-09-28 2008-05-22 Surmodics, Inc. Implantable medical device with apertures for delivery of bioactive agents
WO2008070557A2 (en) * 2006-12-01 2008-06-12 Women & Infants Hospital Organometallic complexes as therapeutic agents
US20080153906A1 (en) * 2006-12-13 2008-06-26 Celly Chander S Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System
WO2008091946A2 (en) 2007-01-24 2008-07-31 Women & Infants Hospital N-amino tetrahydrothiazine derivatives, method of manufacture and use
US8741329B2 (en) 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
ES2718612T3 (es) 2007-12-20 2019-07-03 Evonik Corp Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual
EP2393513B1 (en) 2009-02-06 2016-10-19 The General Hospital Corporation Methods of treating vascular lesions
EP2246063A1 (en) 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. Sustained release formulations comprising GnRH analogues
EP2437684B1 (en) 2009-06-03 2022-06-15 ForSight Vision5, Inc. Anterior segment drug delivery
CA2807225A1 (en) 2010-08-06 2012-02-09 Miho Maeda Pharmaceutical preparation for controlling water-soluble drug release
CA2807224A1 (en) 2010-08-06 2012-02-09 Dainippon Sumitomo Pharma Co., Ltd. Preparation for treatment of spinal cord injury
EP2755615B1 (en) 2011-09-14 2022-04-06 Forsight Vision5, Inc. Ocular insert apparatus
DK2911623T3 (da) 2012-10-26 2019-10-28 Forsight Vision5 Inc Oftalmisk system til langvarig frigivelse af lægemiddel til øjet
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
JP6359390B2 (ja) * 2014-09-05 2018-07-18 テルモ株式会社 インプラントデバイスおよびインプラントデバイス植え込み具
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
EP3522825B1 (en) * 2016-10-05 2023-06-07 Titan Pharmaceuticals, Inc. Implantable devices for drug delivery with reduced burst release
MX2020014160A (es) * 2018-06-25 2021-03-09 Titan Pharmaceuticals Inc Implantes para liberacion de sustancias farmaceuticas lipofilicas o anfifilicas.
KR102442807B1 (ko) * 2021-01-29 2022-09-15 주식회사 티온랩테라퓨틱스 초기 방출 제어된 데포 조성물 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
FR2240817B1 (da) * 1973-08-16 1981-04-17 Roland Offsetmaschf
JPS5513381Y2 (da) * 1974-02-21 1980-03-26
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
JPS58781B2 (ja) * 1978-07-17 1983-01-07 風早 清志 畳表の自動裁断装置
US4191741A (en) * 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
DE3022800A1 (de) * 1980-06-19 1982-01-07 Bayer Ag, 5090 Leverkusen Verfahren zur temperaturregelung exothermer reaktionen durch ueberhitzung von wasserdampf
JPS62174031A (ja) * 1985-10-11 1987-07-30 Sumitomo Pharmaceut Co Ltd 高分子量薬物含有徐放性製剤
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
ES2022454B3 (es) * 1986-06-17 1991-12-01 Recordati Ind Chimica E Farm S P A Sistema terapeutico para la liberacion controlada de drogas.
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
DK606288D0 (da) * 1988-03-24 1988-10-31 Bukh Meditec Praeparat
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
JPH02142738A (ja) * 1988-11-24 1990-05-31 Nippon Zeon Co Ltd 徐放性医薬製剤およびその製法
JP3118009B2 (ja) * 1991-04-16 2000-12-18 住友製薬株式会社 多層構造を有するコラーゲンおよび／またはゼラチン製剤の製造方法
JPH06321803A (ja) * 1993-05-17 1994-11-22 Kirin Brewery Co Ltd 水溶性ペプチドホルモンの徐放性製剤

Also Published As

Publication number Publication date
EP0659406B1 (en) 2000-03-22
NZ277548A (en) 1997-05-26
JP3720386B2 (ja) 2005-11-24
PT659406E (pt) 2000-06-30
US5851547A (en) 1998-12-22
CN1107497C (zh) 2003-05-07
DE69423582D1 (de) 2000-04-27
WO1995017881A1 (en) 1995-07-06
CA2139058A1 (en) 1995-06-28
ATE190836T1 (de) 2000-04-15
AU1280995A (en) 1995-07-17
CA2139058C (en) 2004-11-16
KR100349960B1 (ko) 2003-03-06
GR3033248T3 (en) 2000-09-29
CN1142763A (zh) 1997-02-12
JPH07187994A (ja) 1995-07-25
EP0659406A2 (en) 1995-06-28
ES2146633T3 (es) 2000-08-16
DE69423582T2 (de) 2000-09-07
AU686713B2 (en) 1998-02-12
EP0659406A3 (en) 1995-11-15

Similar Documents

Publication Publication Date Title
DK0659406T3 (da) Lægemiddelformulering med reguleret afgivelse
ATE195252T1 (de) Wirkstoffabgabevorrichtung mit gesteuerter freigabe
GEP20022833B (en) New Controlled Release Bead, Method of Producing the Same and Multiple Unit Formulation Comprising It
MX9700850A (es) Formulaciones y metodos para proporcionar anestesia local prolongada.
TR199802667T2 (xx) Spiro-piperidin t�revleri ve terap�tik ajan olarak kullan�mlar�.
ES2093917T3 (es) Endoprotesis luminar y su procedimiento de preparacion.
BR9509183A (pt) Agente antiinflamatório para uso externo
ID27502A (id) Turunan-turunan 3-(amino-atau aminoalkil) piridinon dan penggunannya untuk pengobatan penyakit-penyakit yang berkaitan dengan hiv
BR9608368A (pt) Método para aumentar a eficácia de um agente microbicida composição microbicida e método para controlar o crescimento de microorganismos
ES2040137T3 (es) Agente para la tincion del pelo y su empleo.
DK1112739T3 (da) Langtidsafgivende depot-præparat
ES491307A0 (es) Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal
NO942396L (no) Preparat med vedvarende frigiving av anti-endotelin substans
EP0262893A3 (en) Ocular insert
ES2152315T3 (es) Xamoneline tartrato.
MY8700599A (en) Oxazole derivatives
DK0540813T3 (da) Acetazolamid-præparat med vedvarende afgift af aktivt stof
DK0659341T3 (da) Fast insecticidt præparat
NO891918D0 (no) Gjoedningsmiddel, fremgangsmaate for dets fremstilling og anvendelse av midlet.
DK0416722T3 (da) Farmaceutiske præparater med differentieret medikamentfrigivelseshastighed
EP0795333A3 (en) TGF-beta regulating substance for treatment of myopia or hyperopia
DE69732612D1 (de) Aktive implantierbare medizinische Vorrichtung und ihr externes Programmiergerät, mit dynamischer Einstellung der Sendeleistung
MX9703084A (es) Aceleradores polimericos para el curado de heridas.
UA43800A (uk) Спосіб лікування перфоративної виразки дванадцятипалої кишки